News
Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
The Consumer Health division of Bayer has selected Interpublic Group (NYSE: IPG) as the global agency partner for all creative, production and media, responsible for marketing activities for some
Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
The Consumer Health division of Bayer has selected Interpublic Group (NYSE: IPG) as the global agency partner for all creative, production and media, responsible for marketing activities for some
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)’s Annual Scientific
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)’s Annual Scientific
EQS-News: Knorr-Bremse acquires duagon Group, enhancing growth of global rail business
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse acquires duagon Group, enhancing growth of global rail business
EQS-News: Verbio SE: Verbio confirms preliminary EBITDA result for 2024/25 and expects significant recovery in FY 2025/26
EQS-News: Verbio SE: Verbio confirms preliminary EBITDA result for 2024/25 and expects significant recovery in FY 2025/26
EQS-News: Energiekontor AG: Energiekontor puts Königsfeld solar park into operation and expands own portfolio – PPA cooperation with Currenta ensures sustainable energy supply in the chemical sector
EQS-Adhoc: Verbio SE: Suspension of dividend for the financial year 2024/25
EQS-Adhoc: Verbio SE: Suspension of dividend for the financial year 2024/25
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
Bayer announced today progress for two potential therapies against Parkinson’s disease (PD). A first participant received randomized treatment in the pivotal Phase III clinical trial, exPDite-2, of
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
Bayer announced today progress for two potential therapies against Parkinson’s disease (PD). A first participant received randomized treatment in the pivotal Phase III clinical trial, exPDite-2, of
EQS-Adhoc: Porsche Automobil Holding SE: Adjustment of the forecast for the adjusted group result after tax 2025
EQS-News: Eckert & Ziegler Gains Approval for GalliaPharm® in Japan
EQS-News: Eckert & Ziegler Gains Approval for GalliaPharm® in Japan
EQS-News: Scout24 acquires Spanish online real estate platforms Fotocasa and Habitaclia
EQS-News: Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47%
EQS-News: Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47%
EQS-News: flatexDEGIRO launches crypto trading in Austria, France, the Netherlands and Spain
EQS-News: HelloFresh SE Announces Intention of Co-Founder and CEO International, Thomas Griesel, to Depart
EQS-Adhoc: HelloFresh SE: Thomas Griesel, co-founder and CEO International of HelloFresh SE, does not intend to extend his Management Board mandate beyond 30 April 2026
EQS-News: Energiekontor AG: Financial close achieved for two further wind park projects in the district of Verden – start of construction ahead
EQS-News: PVA TePla hosts successful Capital Markets Day 2025 and provides strategic outlook